Coronary disease & ACSCohort study

Use of Electrocardiograms to Identify Coronary Artery Disease

JACC AdvPublished

  • retrospective study
  • 10-fold cross-validation
  • external validation set

Authors' conclusion

This study demonstrated the clinical utility of a deep learning artificial intelligence algorithm to analyze a digital 12-lead ECG to predict the presence of clinically significant CAD as determined by coronary angiography.

Study context

Population
Patients presenting for coronary angiography with a resting 12-lead digital electrocardiogram (ECG) recorded within 90 days priorpatients with a resting 12-lead digital ECG within 90 days prior to coronary angiography, 2019 to 2021
Participants
16,476 patients
Exposure
Cross-validation cohort vs External validation

Further findings

Prediction of clinically significant CAD

Prevalence of clinically significant CAD

Positive predictive value Cross-validation cohort 91.7% (95% CI: 89.9%-93.4%) · External validation 82.5% (95% CI: 75.9%-89.2%)

Negative predictive value Cross-validation cohort 72.8% (95% CI: 69.6%-76.0%) · External validation 88.1% (95% CI: 84.0%-92.1%)

Area under the curve Cross-validation cohort 91.4% (95% CI: 89.4%-94.4%) · External validation 92.4% (95% CI: 89.7%-95.1%)

Original publication

Use of Electrocardiograms to Identify Coronary Artery Disease. JACC Adv. Published 29 January 2026. doi:10.1016/j.jacadv.2025.102573

Summarised from the published abstract; every number is checked against it